Nadya Lisovoder

Nadya Lisovoder is an accomplished Doctor of Medicine with 15 years of domestic and international experience in academic and clinical studies in the pharmaceutical, diagnostic and medical devices industry. Dr. Lisovoder is a regulatory expert and has been clinical adviser to public biotech companies and a range of incubator and acceleration including Furtux- a J&J Innovation and Takeda program. Nadya has managed clinical trials across multiple therapy areas in complex, multi-site studies encompassing Israel, EU and the US for large Pharma companies such as Schering Plough, as well as innovative start-ups. Since 2012, Dr. Lisovoder has been leading for the Israeli government biomedical research in 7 hospitals in northern Israel in cooperation with universities, international Pharma companies, global CROs and biotech companies.

In 2016 Nadya founded Galilee Clinical Research Ltd, a multi- faceted entrepreneurial centre providing regulatory consulting to support product development and prepare companies for FDA meetings and filings, providing regulatory guidance for successful implementation and regulatory compliance of clinical trial programs.